Neuren Pharmaceuticals (NEU.AX) Earnings Analysis
Neuren Pharmaceuticals (NEU.AX) next reports earnings on 2026-08-25, consensus EPS 0.07451 AUD. Last quarter (2025-08-26) it beat with EPS 0.1165 AUD vs 0.1165 AUD est (0%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 68.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NEU.AX next report earnings?
| Next earnings date | 2026-08-25 |
|---|---|
| Consensus EPS estimate | 0.07451 AUD |
| Revenue estimate | 0.03B |
NEU.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-26 | 0.1165 AUD | 0.1165 AUD | 0% | Beat |
| 2025-02-27 | 1.03 AUD | 1.04 AUD | -1% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
NEU.AX valuation and analyst view
| Trailing P/E | 68.58 |
|---|---|
| Trailing EPS | 0.24034 AUD |
| Price / book | 6.16 |
| Dividend yield | 0.00% |
| Market cap | 2.19B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Neuren Pharmaceuticals (NEU.AX)'s next earnings date?
Neuren Pharmaceuticals is next scheduled to report on 2026-08-25, with a consensus EPS estimate of 0.07451 AUD and revenue estimate of 0.03B.
Did NEU.AX beat earnings last quarter?
In its 2025-08-26 report, NEU.AX posted EPS of 0.1165 AUD versus a 0.1165 AUD estimate — a beat of 0%.
What is NEU.AX's earnings track record?
Over the last 2 reported quarters with consensus data, NEU.AX beat estimates 1 times (50%).
What is NEU.AX's current P/E ratio and EPS?
NEU.AX trades at a trailing P/E of 68.58 on trailing EPS of 0.24033570687875128 AUD.
What do analysts rate NEU.AX?
NEU.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.